Clinical Significance of Immunohistochemical Markers of Diffuse Large B-Cell Lymphoma In the Rituximab Era.

被引：0
|
作者：
Hayama, Miyuki [1 ]
Okamoto, Masataka [2 ]
Hagiwara, Yuki [1 ]
Tanae, Ken [1 ]
Kohri, Mika [1 ]
Takahashi, Naoki [1 ]
Yoshino, Tadashi [2 ]
Ohshima, Koichi [2 ]
Niitsu, Nozomi [1 ]
机构：
[1] Saitama Med Univ, Int Med Ctr, Dept Hematol, Hidaka, Japan
[2] ALTSG, Nagoya, Aichi, Japan
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：752 / 752
页数：1
相关论文
共 50 条
  • [21] Predictive and Prognostic Significance of Immunohistochemical Markers and Blood Absolute Lymphocyte Count in Diffuse Large B-Cell Lymphoma in Rituximab Era: A Polish Lymphoma Research Group (PLRG) Multicenter Retrospective Analysis
    Czyz, Anna
    Joks, Monika
    Drozd-Sokolowska, Joanna E.
    Knopinska-Posluszny, Wanda
    Zawartko, Magdalena
    Mizera-Nyczak, Ewa
    Dytfeld, Dominik
    Zdziarska, Barbara
    Jedrzejczak, Wiktor-Wieslaw
    Komarnicki, Mieczyslaw
    BLOOD, 2014, 124 (21)
  • [22] Rebirth of radiotherapy for elderly patients with diffuse large B-cell lymphoma in the rituximab era
    Flowers, Christopher R.
    Cohen, Jonathon B.
    Khan, Mohammad K.
    LEUKEMIA & LYMPHOMA, 2015, 56 (03) : 557 - 558
  • [23] A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era
    Hosein, Peter J.
    Maragulia, Jocelyn C.
    Salzberg, Matthew P.
    Press, Oliver W.
    Habermann, Thomas M.
    Vose, Julie M.
    Bast, Martin
    Advani, Ranjana H.
    Tibshirani, Robert
    Evens, Andrew M.
    Islam, Nahida
    Leonard, John P.
    Martin, Peter
    Zelenetz, Andrew D.
    Lossos, Izidore S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (03) : 358 - 363
  • [24] The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
    T Kobayashi
    J Kuroda
    I Yokota
    K Tanba
    T Fujino
    S Kuwahara
    R Isa
    J Yamaguchi
    E Kawata
    T Akaogi
    H Uchiyama
    H Kaneko
    N Uoshima
    Y Kobayashi
    S Teramukai
    M Taniwaki
    Blood Cancer Journal, 2016, 6 : e383 - e383
  • [25] The Kyoto Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Kobayashi, Tsutomu
    Kuroda, Junya
    Yokota, Isao
    Tanba, Kazuna
    Taki, Tomohiko
    Fujino, Takahiro
    Kuwahara, Saeko
    Isa, Reiko
    Yamaguchi, Junko
    Kawata, Eri
    Akaogi, Teruaki
    Uchiyama, Hitoji
    Kaneko, Hiroto
    Uoshima, Nobuhiko
    Kobayashi, Yutaka
    Teramukai, Satoshi
    Taniwaki, Masafumi
    BLOOD, 2015, 126 (23)
  • [26] Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era
    Huang, Yu-Chung
    Liu, Chun-Yu
    Lu, Hsueh-Ju
    Liu, Han-Tsung
    Hung, Man-Hsin
    Hong, Ying-Chung
    Hsiao, Liang-Tsai
    Gau, Jyh-Pyng
    Liu, Jin-Hwang
    Hsu, Hui-Chi
    Chiou, Tzeon-Jye
    Chen, Po-Min
    Tzeng, Cheng-Hwai
    Yu, Yuan-Bin
    ANNALS OF HEMATOLOGY, 2013, 92 (11) : 1513 - 1520
  • [27] Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era
    Takahashi, Hiroyuki
    Tomita, Naoto
    Yokoyama, Masahiro
    Tsunoda, Saburo
    Yano, Takahiro
    Murayama, Kayoko
    Hashimoto, Chizuko
    Tamura, Kazuo
    Sato, Kazuya
    Ishigatsubo, Yoshiaki
    CANCER, 2012, 118 (17) : 4166 - 4172
  • [28] The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
    Kobayashi, T.
    Kuroda, J.
    Yokota, I.
    Tanba, K.
    Fujino, T.
    Kuwahara, S.
    Isa, R.
    Yamaguchi, J.
    Kawata, E.
    Akaogi, T.
    Uchiyama, H.
    Kaneko, H.
    Uoshima, N.
    Kobayashi, Y.
    Teramukai, S.
    Taniwaki, M.
    BLOOD CANCER JOURNAL, 2016, 6 : e383 - e383
  • [29] Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era
    Yu-Chung Huang
    Chun-Yu Liu
    Hsueh-Ju Lu
    Han-Tsung Liu
    Man-Hsin Hung
    Ying-Chung Hong
    Liang-Tsai Hsiao
    Jyh-Pyng Gau
    Jin-Hwang Liu
    Hui-Chi Hsu
    Tzeon-Jye Chiou
    Po-Min Chen
    Cheng-Hwai Tzeng
    Yuan-Bin Yu
    Annals of Hematology, 2013, 92 : 1513 - 1520
  • [30] PROGNOSTIC SIGNIFICANCE OF IMMUNOHISTOCHEMICAL MARKERS IN R-CHOP TREATED DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS
    Picleanu, A. -M.
    Patrascu, S.
    Mogoanta, L.
    HAEMATOLOGICA, 2017, 102 : 826 - 827
12345